CLINICAL_TRIALS
withdrawal
· 2020-04-22
Clinical Trial Update: Legend: TRELEGY Real World Chronic Obstructive Pulmonary Disease (COPD) Effectiveness Study [Phase 4]
Summary
A phase 4 real-world effectiveness study of TRELEGY for chronic obstructive pulmonary disease has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 4 | Status: WITHDRAWN